Status:
RECRUITING
Percutaneous Ultrasound-guided Neuromodulation to Improve Gait Rehabilitation in Patients Who Have Suffered a Stroke.
Lead Sponsor:
Alejandro Martín García
Conditions:
Ictus
Gait Disorders, Neurologic
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if percutaneous ultrasound-guided neuromodulation (NMP-e) can improve gait rehabilitation in adults who have suffered a stroke. The main questions it aims t...
Detailed Description
This study is designed to evaluate the effectiveness of ultrasound-guided percutaneous neuromodulation (PNM) combined with conventional physiotherapy in improving gait and functional outcomes in adult...
Eligibility Criteria
Inclusion
- Be between 18 and 70 years of age;
- Have suffered a stroke (CVA);
- Be in the subacute or chronic phase of the disease;
- Be able to walk 10 meters without assistance from another person;
- Currently be undergoing physiotherapy with conservative techniques;
- Be able to understand the technique being applied;
- Sign the informed consent form.
Exclusion
- Belonephobia (fear of needles);
- Allergy to needles or metals;
- Presence of uncontrolled coagulopathies;
- Presence of uncontrolled arterial disease;
- Pregnancy;
- Dermatological disorders;
- Presence of diseases such as systemic inflammatory disorders (e.g., rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, or septic arthritis);
- Presence of diseases such as tumors, cancer, or metastases;
- Having received invasive physiotherapy treatment in the last 4 weeks.
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07196878
Start Date
September 15 2025
End Date
December 1 2027
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad de Zaragoza
Zaragoza, Aragon, Spain, 50009